デフォルト表紙
市場調査レポート
商品コード
1472035

骨盤臓器脱修復の世界市場-世界の業界分析、規模、シェア、成長、動向、地域別見通し、予測(2024年~2031年)

Pelvic Organ Prolapse Repair Market - Global Pelvic Organ Prolapse Repair Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031 -

出版日: | 発行: Fairfield Market Research | ページ情報: 英文 202 Pages | 納期: 2~5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
骨盤臓器脱修復の世界市場-世界の業界分析、規模、シェア、成長、動向、地域別見通し、予測(2024年~2031年)
出版日: 2024年04月22日
発行: Fairfield Market Research
ページ情報: 英文 202 Pages
納期: 2~5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の骨盤臓器脱(POP)修復の市場規模は、2024年の4億2,000万米ドルから2031年には6億米ドルに達すると予測されています。同市場は、2024年から2031年にかけての期間中、5.23%のCAGRで拡大する見込みです。

市場の拡大は、いくつかの極めて重要な要因によって後押しされています。第一に、世界人口の高齢化と出産やホルモンの変化などが相まって、骨盤臓器脱の有病率が高まっています。人口統計が進化し続けるにつれ、それに伴って修復手術の需要も急増すると予想されます。

第二に、手術技術と医療機器の著しい進歩が骨盤臓器脱修復の状況を一変させました。腹腔鏡手術やロボット支援手術を含む低侵襲手術の革新は、従来の開腹手術に比べて回復時間の短縮、合併症発生率の低下、患者満足度の向上につながっています。

さらに、骨盤底障害に対する認識が高まり、治療法の選択肢が増えたことで、骨盤臓器脱に対する医療支援を求める患者の意欲が高まっています。ヘルスケア教育への取り組み、アドボカシー活動、ヘルスケアサービスへのアクセス向上は、早期診断と治療をさらに促進し、市場成長を後押ししています。

当レポートでは、世界の骨盤臓器脱修復市場について調査し、市場の概要とともに、治療別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナ・ロシア紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の骨盤臓器脱修復市場の見通し、2019年~2031年

  • 世界の骨盤臓器脱修復市場の見通し、治療別、金額(10億米ドル)、2019年~2031年
  • 世界の骨盤臓器脱修復市場の見通し、用途別、金額(10億米ドル)、2019年~2031年
  • 世界の骨盤臓器脱修復市場の見通し、エンドユーザー別、金額(10億米ドル)、2019年~2031年
  • 世界の骨盤臓器脱修復市場の見通し、地域別、金額(10億米ドル)、2019年~2031年

第4章 北米の骨盤臓器脱修復市場の見通し、2019年~2031年

第5章 欧州の骨盤臓器脱修復市場の見通し、2019年~2031年

第6章 アジア太平洋の骨盤臓器脱修復市場の見通し、2019年~2031年

第7章 ラテンアメリカの骨盤臓器脱修復市場の見通し、2019年~2031年

第8章 中東・アフリカの骨盤臓器脱修復市場の見通し、2019年~2031年

第9章 競合情勢

  • メーカー別と用途別のヒートマップ
  • 企業市場シェア分析、2023年
  • 競合ダッシュボード
  • 企業プロファイル
    • Johnson & Johnson Services, Inc.
    • Coloplast A/S
    • Dipromed Srl
    • Boston Scientific Corporation
    • PFM medical ag
    • Promedon Group
    • Caldera Medical
    • Cook Medical
    • Medgyn Products, Inc.
    • Cooper Surgical, Inc.
    • DIMA S.L.
    • Digitimer Ltd.
    • Bray Group Ltd.
    • Medesign Ingenieur-Consulting GmbH
    • Panpac Medical Corp.

第10章 付録

目次

Global pelvic organ prolapse (POP) repair market is on track for substantial growth, with projections indicating a valuation of US$600 million by 2031, soaring from US$420 million in 2024. This impressive expansion is anticipated to occur at a compound annual growth rate (CAGR) of 5.23% during the period spanning 2024 to 2031.

Key Growth Drivers

The market's upward trajectory is fueled by several pivotal factors. Firstly, the ageing Global population, combined with occurrences such as childbirth and hormonal changes, contribute to a heightened prevalence of pelvic organ prolapse. As demographics continue to evolve, the demand for repair procedures is expected to surge accordingly.

Secondly, significant advancements in surgical techniques and medical devices have transformed the landscape of pelvic organ prolapse repair. Innovations in minimally invasive procedures, including laparoscopic and robotic-assisted surgeries, have led to reduced recovery times, lower complication rates, and enhanced patient satisfaction compared to traditional open surgeries.

Moreover, increased awareness of pelvic floor disorders and the availability of treatment options have spurred greater patient willingness to seek medical assistance for pelvic organ prolapse. Healthcare education initiatives, advocacy efforts, and improved access to healthcare services further facilitate early diagnosis and treatment, thus propelling market growth.

Major Growth Barriers

Despite the promising outlook, the market faces notable challenges. Safety concerns surrounding certain surgical techniques and devices, particularly mesh implants, have prompted heightened regulatory scrutiny and stricter approval processes. Legal challenges stemming from product liability claims also pose hurdles to market expansion, contributing to uncertainty and potentially deterring investment in research and development.

Additionally, the emergence of alternative treatment modalities, such as pelvic floor physical therapy and lifestyle modifications, presents a restraint to market growth. Some patients may prefer conservative management approaches over surgical interventions, impacting adoption rates for pelvic organ prolapse repair procedures.

Key Trends and Opportunities

Several trends and opportunities shape the future trajectory of the pelvic organ prolapse repair market. Notably, there is a significant shift towards minimally invasive procedures, driven by associated benefits such as shorter hospital stays, faster recovery times, and reduced post-operative pain.

Furthermore, there is a growing interest in biologic and tissue-engineered implants as alternatives to synthetic mesh materials. These implants offer the potential for improved integration with host tissues and reduced risk of complications, driving research and development activity in this area.

Moreover, the development of patient-specific treatment approaches presents a significant opportunity for market players to enhance treatment outcomes and gain a competitive edge. Personalized medicine approaches, tailored to individual patient characteristics, have the potential to improve clinical outcomes and patient satisfaction.

Expansion into emerging markets, particularly in regions such as Asia-Pacific, Latin America, and the Middle East, also offers significant growth potential. Rising healthcare expenditure, improving healthcare infrastructure, and increasing awareness of pelvic floor disorders contribute to the fertile ground for market expansion in these regions.

Regional Frontrunners

Currently, North America leads the pelvic organ prolapse repair market, owing to factors such as a higher prevalence of POP, robust healthcare infrastructure, and the presence of established industry players. Europe follows closely, with a strong presence of Global industry leaders and rising awareness of pelvic floor disorders.

The Asia Pacific region is emerging as a significant player in the market, fueled by increasing awareness, a large and ageing female population, and expanding healthcare infrastructure. Medical tourism further accelerates market growth in this region.

Leaders in Global Pelvic Organ Prolapse Repair Space

Key players driving innovation and growth in the pelvic organ prolapse repair market include:

Johnson & Johnson Services, Inc.

Coloplast A/S

Dipromed Srl

Boston Scientific Corporation (American Medical Systems Inc.)

pfm medical ag

Betatech Medical

Promedon Group

Caldera Medical

Cook Medical

MEDGYN PRODUCTS, INC.

CooperSurgical, Inc.

DIMA S.L.

Digitimer Ltd

Bray Group Ltd,

medesign Ingenieur-Consulting GmbH

Panpac Medical Corp.

for.me.sa.

Bioteque America Inc.

Bliss GVS Pharma

Panpac Medical Corporation

Personal Medical Corporation

Dr. Arabin GmbH & Co.

Kangge Medical

Integra Lifesciences

Wallach Surgical Devices

Medesign

Market Segmentation

The Global Pelvic Organ Prolapse Repair Market is segmented as follows:

By Treatment:

Non-surgical:

Pessary

Pelvic Floor Muscle Therapy

Surgical:

Colpocleisis

Colporrhaphy

Sacrocolpopexy

Sacrohysteropexy

Uterosacral or Sacrospinous Ligament Fixation

By Application:

Cystocele

Urethrocele

Enterocele

Uterine Prolapse

Posterior Vaginal Wall Prolapse (dropped rectum)

By End User:

Hospitals

Specialized Clinics

Female Care Facilities

By Region:

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Non-surgical
        • 3.1.1.1.1. Pessary
        • 3.1.1.1.2. Pelvic Floor Muscle Therapy
      • 3.1.1.2. Surgical
        • 3.1.1.2.1. Colpocleisis
        • 3.1.1.2.2. Colporrhaphy
        • 3.1.1.2.3. Sacrocolpopexy
        • 3.1.1.2.4. Sacrohysteropexy
        • 3.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Cystocele
      • 3.2.1.2. Urethrocele
      • 3.2.1.3. Enterocele
      • 3.2.1.4. Uterine Prolapse
      • 3.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Specialized Clinics
      • 3.3.1.3. Female Care Facilities
  • 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Bn), 2019 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. By Treatment
        • 4.1.1.1.1. Pessary
        • 4.1.1.1.2. Pelvic Floor Muscle Therapy
      • 4.1.1.2. Surgical
        • 4.1.1.2.1. Colpocleisis
        • 4.1.1.2.2. Colporrhaphy
        • 4.1.1.2.3. Sacrocolpopexy
        • 4.1.1.2.4. Sacrohysteropexy
        • 4.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Cystocele
      • 4.2.1.2. Urethrocele
      • 4.2.1.3. Enterocele
      • 4.2.1.4. Uterine Prolapse
      • 4.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialized Clinics
      • 4.3.1.3. Female Care Facilities
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.2. U.S. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.3. U.S. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 4.4.1.4. Canada Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 4.4.1.5. Canada Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 4.4.1.6. Canada Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. By Treatment
        • 5.1.1.1.1. Pessary
        • 5.1.1.1.2. Pelvic Floor Muscle Therapy
      • 5.1.1.2. Surgical
        • 5.1.1.2.1. Colpocleisis
        • 5.1.1.2.2. Colporrhaphy
        • 5.1.1.2.3. Sacrocolpopexy
        • 5.1.1.2.4. Sacrohysteropexy
        • 5.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Cystocele
      • 5.2.1.2. Urethrocele
      • 5.2.1.3. Enterocele
      • 5.2.1.4. Uterine Prolapse
      • 5.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialized Clinics
      • 5.3.1.3. Female Care Facilities
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Pelvic Organ Prolapse Repair Market By Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.2. Germany Pelvic Organ Prolapse Repair Market By Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.3. Germany Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.4. U.K. Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.5. U.K. Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.6. U.K. Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.7. France Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.8. France Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.9. France Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.10. Italy Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.11. Italy Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.12. Italy Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.13. Turkey Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.14. Turkey Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.15. Turkey Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.16. Russia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.17. Russia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.18. Russia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 5.4.1.19. Rest of Europe Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 5.4.1.20. Rest of Europe Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 5.4.1.21. Rest of Europe Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. By Treatment
        • 6.1.1.1.1. Pessary
        • 6.1.1.1.2. Pelvic Floor Muscle Therapy
      • 6.1.1.2. Surgical
        • 6.1.1.2.1. Colpocleisis
        • 6.1.1.2.2. Colporrhaphy
        • 6.1.1.2.3. Sacrocolpopexy
        • 6.1.1.2.4. Sacrohysteropexy
        • 6.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Cystocele
      • 6.2.1.2. Urethrocele
      • 6.2.1.3. Enterocele
      • 6.2.1.4. Uterine Prolapse
      • 6.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialized Clinics
      • 6.3.1.3. Female Care Facilities
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.2. China Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.3. China Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.4. Japan Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.5. Japan Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.6. Japan Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.7. South Korea Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.8. South Korea Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.9. South Korea Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.10. India Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.11. India Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.12. India Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.13. Southeast Asia Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.14. Southeast Asia Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.15. Southeast Asia Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 6.4.1.16. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 6.4.1.17. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 6.4.1.18. Rest of Asia Pacific Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. By Treatment
        • 7.1.1.1.1. Pessary
        • 7.1.1.1.2. Pelvic Floor Muscle Therapy
      • 7.1.1.2. Surgical
        • 7.1.1.2.1. Colpocleisis
        • 7.1.1.2.2. Colporrhaphy
        • 7.1.1.2.3. Sacrocolpopexy
        • 7.1.1.2.4. Sacrohysteropexy
  • 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Cystocele
      • 7.2.1.2. Urethrocele
      • 7.2.1.3. Enterocele
      • 7.2.1.4. Uterine Prolapse
      • 7.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialized Clinics
      • 7.3.1.3. Female Care Facilities
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.2. Brazil Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.3. Brazil Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.4. Mexico Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.5. Mexico Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.6. Mexico Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.7. Argentina Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.8. Argentina Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.9. Argentina Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 7.4.1.10. Rest of Latin America Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 7.4.1.11. Rest of Latin America Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 7.4.1.12. Rest of Latin America Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2019 - 2031

  • 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Treatment, Value (US$ Bn), 2019 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. By Treatment
        • 8.1.1.1.1. Pessary
        • 8.1.1.1.2. Pelvic Floor Muscle Therapy
      • 8.1.1.2. Surgical
        • 8.1.1.2.1. Colpocleisis
        • 8.1.1.2.2. Colporrhaphy
        • 8.1.1.2.3. Sacrocolpopexy
        • 8.1.1.2.4. Sacrohysteropexy
        • 8.1.1.2.5. Uterosacral or Sacrospinous Ligament Fixation
  • 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, By Application, Value (US$ Bn), 2019 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Cystocele
      • 8.2.1.2. Urethrocele
      • 8.2.1.3. Enterocele
      • 8.2.1.4. Uterine Prolapse
      • 8.2.1.5. Posterior Vaginal Wall Prolapse (Dropped Rectum)
  • 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialized Clinics
      • 8.3.1.3. Female Care Facilities
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2019 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.2. GCC Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.3. GCC Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.4. South Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.5. South Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.6. South Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.7. Egypt Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.8. Egypt Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.9. Egypt Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.10. Nigeria Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.11. Nigeria Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.12. Nigeria Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Treatment, Value (US$ Bn), 2019 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by Application, Value (US$ Bn), 2019 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Pelvic Organ Prolapse Repair Market by End User, Value (US$ Bn), 2019 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Johnson & Johnson Services, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Coloplast A/S
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Dipromed Srl
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Boston Scientific Corporation (American Medical Systems Inc.)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. PFM medical ag
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Promedon Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Caldera Medical
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Cook Medical
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Medgyn Products, Inc.
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Cooper Surgical, Inc.
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. DIMA S.L.
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. Digitimer Ltd.
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Bray Group Ltd.
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development
    • 9.4.14. Medesign Ingenieur-Consulting GmbH
      • 9.4.14.1. Company Overview
      • 9.4.14.2. Product Portfolio
      • 9.4.14.3. Financial Overview
      • 9.4.14.4. Business Strategies and Development
    • 9.4.15. Panpac Medical Corp.
      • 9.4.15.1. Company Overview
      • 9.4.15.2. Product Portfolio
      • 9.4.15.3. Financial Overview
      • 9.4.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations